Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationWatch the MHRA webinar on Implementing the new UK Clinical Trials regulations, which took place on Thursday, 12 March 2026.
The MHRA highlights the importance of international collaboration to drive innovation in healthcare regulation.
A new approach to the Innovative Licensing and Access Pathway aims to provide earlier guidance and greater predictability for developers.
An update outlining MHRA’s progress and future direction for improving clinical trial pathways in the UK.
UK guidance sets out how to make patient information clearer and more accessible.
The EMA Management Board has shared updates and key decisions from its March 2026 meeting.
The European Medicines Agency has launched new tools to support faster development of promising medicines.
The FDA has issued draft guidance promoting the use of non animal methods in drug development.
The Health Research Authority is seeking feedback to measure progress in improving study set up across the UK.
A new joint approval process aims to speed up patient access to innovative medicines in the UK.